STOCK TITAN

Femasys (FEMY) CTO reports common stock and option holdings in Form 3

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Femasys Inc. Chief Technology Officer Jeremy Alexander Sipos filed an initial statement of beneficial ownership of company securities. He directly holds 46,278 shares of Femasys common stock. In addition, he reports several employee stock options to buy common stock.

The options cover different grants with exercise prices ranging from $0.80 to $6.12 per share and expiration dates between June 30, 2027 and January 28, 2035. Some grants are fully vested, while others vest in equal installments over three or four years beginning on dates in 2023, 2024, and 2025.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Sipos Jeremy Alexander

(Last) (First) (Middle)
C/O FEMASYS INC.
3950 JOHNS CREEK COURT, SUITE 100

(Street)
SUWANEE GA 30024

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
12/16/2025
3. Issuer Name and Ticker or Trading Symbol
FEMASYS INC [ FEMY ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Technology Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 46,278 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy) (1) 06/30/2027 Common Stock 27,778 $3.24 D
Employee Stock Option (Right to Buy) (2) 12/13/2029 Common Stock 3,334 $6.12 D
Employee Stock Option (Right to Buy) (3) 01/26/2032 Common Stock 14,800 $3 D
Employee Stock Option (Right to Buy) (4) 04/24/2033 Common Stock 14,800 $0.87 D
Employee Stock Option (Right to Buy) (5) 02/01/2034 Common Stock 34,700 $0.8 D
Employee Stock Option (Right to Buy) (6) 01/28/2035 Common Stock 44,411 $1.05 D
Employee Stock Option (Right to Buy) (7) 01/28/2035 Common Stock 34,700 $1.05 D
Explanation of Responses:
1. Fully vested.
2. Fully vested.
3. Fully vested.
4. The shares underlying the stock option vest equally in installments over 4 years beginning on April 24, 2023.
5. The shares underlying the stock option vest equally in installments over 4 years beginning on February 1, 2024.
6. The shares underlying the stock option vest equally in installments over 3 years beginning on January 28, 2025.
7. The shares underlying the stock option vest equally in installments over 4 years beginning on January 28, 2025.
Remarks:
Exhibit 24 - Power of Attorney
/s/ Kathy Lee-Sepsick, Attorney-in-fact 02/17/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does Femasys Inc. (FEMY) Chief Technology Officer report owning in this Form 3?

The Chief Technology Officer reports direct ownership of 46,278 shares of Femasys common stock. He also lists multiple employee stock options giving him rights to buy additional common shares at preset exercise prices.

How many Femasys (FEMY) common shares does the insider directly hold?

The insider directly holds 46,278 shares of Femasys Inc. common stock. This holding is reported in Table I as non-derivative securities beneficially owned with ownership form marked as Direct (D) and no indication of indirect ownership structures.

What stock options are disclosed by the Femasys (FEMY) Chief Technology Officer?

He discloses several Employee Stock Option (Right to Buy) grants on Femasys common stock. These include options over 27,778, 3,334, and 14,800 shares, among others, all held directly, with specified exercise prices and expiration dates.

What are the exercise prices and expirations of the Femasys (FEMY) options reported?

Reported employee stock options carry exercise prices from $0.80 to $6.12 per share. Expiration dates range from June 30, 2027 through January 28, 2035, as shown in the derivative securities table for each individual grant.

How do the Femasys (FEMY) stock options held by the CTO vest?

Three option grants are described as fully vested. Other grants vest equally in installments over three or four years, beginning on April 24, 2023, February 1, 2024, and January 28, 2025, according to the explanatory footnotes.

Is the Femasys (FEMY) insider ownership reported as direct or indirect?

All reported holdings in this statement are marked as Direct (D). Both the 46,278 common shares and each employee stock option grant list ownership form as direct, with no nature of indirect beneficial ownership described in the tables or footnotes.
FEMASYS INC

NASDAQ:FEMY

FEMY Rankings

FEMY Latest News

FEMY Latest SEC Filings

FEMY Stock Data

30.24M
17.54M
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
SUWANEE